title: Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?
authors.forename: Chien-Wei
authors.initials: CW
authors.lastname: Su
authors.forename: Jaw-Ching
authors.initials: JC
authors.lastname: Wu
authors.forename: Shou-Dong
authors.initials: SD
authors.lastname: Lee
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D019233:Retreatment; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D019259:Lamivudine; C413685:entecavir; D006147:Guanine